COMMUNIQUÉS West-GlobeNewswire

Align Technology Ongoing Support of Orthodontic and Dental Research
15/11/2018
2019 Grant Application Process Now Open for up to $300,000 in Funding SAN JOSE, Calif., Nov. 15, 2018 (GLOBE NEWSWIRE) -- Align Technology, Inc. (NASDAQ: ALGN) today announced the opening of its 2019 Research Award [...]
Soleno Therapeutics Presents Clinical Fat Loss Data on DCCR at the Obesity Society Meeting 2018
15/11/2018
DCCR treatment resulted in statistically significant decreases in body fat in subjects with Prader-Willi Syndrome REDWOOD CITY, Calif., Nov. 15, 2018 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (NASDAQ:SLNO), a [...]
Inovio Prepares for Growth & Commercialization With Leadership Appointments
15/11/2018
Prominent immunologist joins Scientific Advisory Board R&D leader appointed Chief Scientific Officer Industry veteran appointed Vice President, Commercial PLYMOUTH MEETING, Pa., Nov. 15, 2018 (GLOBE NEWSWIRE) -- [...]
Rhythm Pharmaceuticals Announces Presentation of Updated Clinical Data from Phase 2 Basket Studies Evaluating Setmelanotide in Alström Syndrome at ObesityWeek 2018
15/11/2018
Company continues on track to initiate combined Phase 3 clinical trial in Alström Syndrome and Bardet-Biedl Syndrome before end of 2018 BOSTON, Nov. 15, 2018 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM [...]
Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2018 Financial Results
15/11/2018
REDWOOD CITY, Calif., Nov. 15, 2018 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, [...]
Genocea To Host a Key Opinion Leader Event November 26th on Latest Advances in Personalized Cancer Immunotherapies
15/11/2018
Event to be webcast live at 12 pm ET CAMBRIDGE, Mass., Nov. 15, 2018 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing personalized cancer immunotherapies, announced [...]
SPR Therapeutics Announces First Use of SPRINT endura Peripheral Nerve Stimulation System to treat Complex Regional Pain Syndrome
15/11/2018
SPRINT System is the least invasive PNS device for CRPS CLEVELAND, Nov. 15, 2018 (GLOBE NEWSWIRE) -- SPR Therapeutics, Inc., a leader in neurostimulation technology for pain management, today announced that Marc Huntoon [...]
Maverick Technology Solutions’ ROSINBOMB™ ROCKET is Now Patent Pending
15/11/2018
Company Files its Second Patent Application with the US Patent and Trademark Office for its innovative consumer extraction press. RENO, Nev., Nov. 15, 2018 (GLOBE NEWSWIRE) -- Maverick Technology Solutions (OTC: MVRK ) [...]
Neuronetics to Present at the 30th Annual Piper Jaffray Healthcare Conference
15/11/2018
MALVERN, Pa., Nov. 15, 2018 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for [...]
Big Health to Offer Better Sleep Program for BJC HealthCare Employees
15/11/2018
Missouri Health System Adds Digital Sleep Improvement Program, Sleepio, to Employee Benefits SAN FRANCISCO, Nov. 15, 2018 (GLOBE NEWSWIRE) -- Big Health , a digital medicine company dedicated to getting millions back to [...]
Progressive Care Inc. Reports Best Nine-Month Revenue Period in Company History in Q3 2018 Financial Filing
15/11/2018
MIAMI, Nov. 15, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced financial results for the quarter ending Sept. 30, 2018, as well [...]
New Pancreatic Ductal Adenocarcinoma Research Published in Journal of Visualized Experiments
15/11/2018
Paper describes well-established protocols for PDAC orthotopic tumor homograft model development and immunoprofiling SAN DIEGO, Nov. 15, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience, a global drug discovery and development [...]
SELLAS Life Sciences Provides Business Update and Reports Third Quarter 2018 Financial Results
15/11/2018
Conference call today at 8:00 a.m. ET NEW YORK, Nov. 15, 2018 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (Nasdaq:SLS) (“SELLAS” or the “Company”), a clinical-stage biopharmaceutical company focused on the [...]
Moleculin Requests FDA Meeting Regarding IND for New Cancer Drug
15/11/2018
Testing confirms ability of WP1732 to target pancreatic cancer HOUSTON, Nov. 15, 2018 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company [...]
HealthEquity Sets Date to Announce Third Quarter Results Fiscal Year 2019
15/11/2018
Attend Citi Investor Conference DRAPER, Utah, Nov. 15, 2018 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), the nation’s largest independent health savings account (HSA) custodian [...]
IMV Inc. to Present at 30th Annual Piper Jaffray Healthcare Conference
15/11/2018
DARTMOUTH, Nova Scotia, Nov. 15, 2018 (GLOBE NEWSWIRE) -- IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical stage immuno-oncology corporation, today announced that Chief Executive Officer Frederic Ors and Chief Financial [...]
Constellation Pharmaceuticals Highlights EZH2 Inhibition Program in Prostate Cancer at Biomedical Conference
15/11/2018
CAMBRIDGE, Mass., Nov. 15, 2018 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals , Inc., (Nasdaq: CNST) a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel [...]
Exalenz Announces Third Quarter 2018 Financial Results
15/11/2018
Third quarter 2018 revenue increased 25% to $3.2 million, compared with $2.5 million in same period in 2017 Third quarter 2018 gross profit increased 60% compared to same period in 2017 MODI’IN, Israel and MANASQUAN, N. [...]
Bio-Path Holdings Reports Third Quarter 2018 Financial Results
15/11/2018
Conference Call to be Held Today at 8:30 A.M. ET HOUSTON, Nov. 15, 2018 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize ® antisense RNAi [...]

Pages